Maverick Capital’s Bristol-Myers Squibb BMY Stock Holding History

Maverick Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-40,241	Closed	-$2.54M	–	686
2021 Q1	$2.54M	Buy	40,241 +17,692	+78%	+$1.1M	0.02%	131
2020 Q4	$1.4M	Buy	22,549 +15,382	+215%	+$946K	0.02%	184
2020 Q3	$432K	Sell	7,167 -58,206	-89%	-$3.5M	0.01%	431
2020 Q2	$3.84M	Sell	65,373 -3,580	-5%	-$214K	0.08%	73
2020 Q1	$3.84M	Sell	68,953 -46,300	-40%	-$2.83M	0.08%	106
2019 Q4	$7.4M	Sell	115,253 -9,259	-7%	-$530K	0.11%	83
2019 Q3	$6.31M	Buy	124,512 +3,512	+3%	+$165K	0.09%	98
2019 Q2	$5.49M	Sell	121,000 -17,060	-12%	-$795K	0.08%	143
2019 Q1	$6.59M	Buy	+138,060	New	+$6.88M	0.09%	137
2018 Q4	–	Sell	-148,610	Closed	-$9.23M	–	262
2018 Q3	$9.23M	Buy	+148,610	New	+$8.82M	0.11%	83

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Maverick Capital's BMY Position: Q2 2021 in Review

Maverick Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 40,241 shares — an estimated $2.54M sold.

Maverick Capital first reported a position in BMY in Q3 2018 and held it in 10 quarters. The position peaked at $9.23M in Q3 2018. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

Maverick Capital reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
Maverick Capital sold 40,241 Bristol-Myers Squibb shares in Q2 2021, an estimated $2.54M.
Maverick Capital first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 10 quarters.
Maverick Capital's Bristol-Myers Squibb position peaked at $9.23M in Q3 2018.
2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Maverick Capital's 13F filing for Q2 2021, filed 16 Aug 2021.